Cargando…
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups
Hemangioblastomas (HBs) of the central nervous system are highly vascular neoplasms that occur sporadically or as a manifestation of von Hippel–Lindau (VHL) disease. Despite their benign nature, HBs are clinically heterogeneous and can be associated with significant morbidity due to mass effects of...
Autores principales: | Woltering, Niklas, Albers, Anne, Müther, Michael, Stummer, Walter, Paulus, Werner, Hasselblatt, Martin, Holling, Markus, Thomas, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616087/ https://www.ncbi.nlm.nih.gov/pubmed/35637626 http://dx.doi.org/10.1111/bpa.13083 |
Ejemplares similares
-
Resection of Intramedullary Hemangioblastoma: Timing of Surgery and Its Impact on Neurological Outcome and Quality of Life
por: Schwake, Michael, et al.
Publicado: (2023) -
Neuropathologic features of central nervous system hemangioblastoma
por: Yoda, Rebecca A., et al.
Publicado: (2022) -
The loss of succinate dehydrogenase B expression is frequently identified in hemangioblastoma of the central nervous system
por: Roh, Tae Hoon, et al.
Publicado: (2019) -
Mixed Reality as a Teaching Tool for Medical Students in Neurosurgery
por: Silvero Isidre, Arturo, et al.
Publicado: (2023) -
Disseminated Hemangioblastoma of the Central Nervous System without Von Hippel-Lindau Disease
por: Chung, Sun-Yoon, et al.
Publicado: (2014)